As of 2024-12-15, the Fair Value of ExpreS2ion Biotech Holding AB (EXPRS2.ST) is -108.01 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 24.40 SEK, the upside of ExpreS2ion Biotech Holding AB is -542.67%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -17.26 | -31.71 | -43.92 | -118.60 | -91.40 | -60.58 |
| YoY growth | -2.59% | -83.77% | -38.51% | -170.02% | 22.94% | -54.39% |
| Market Cap (mil) | 51.25 |
| P/E | |
| Forward P/E |
| EPS | -21.60 |
| Avg earnings growth rate | -54.39% |
| TTM earnings | -45.37 |